T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

NCT05756556 · clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
68
Enrollment
INDUSTRY
Sponsor class

Stopped Change in drug development and lifecycle management and decide to suspend this study

Conditions

Interventions

Sponsor

ImmVira Pharma Co. Ltd